SCHEMBL21936957

SCHEMBL21936957

c1ccc(N(c2ccccc2)c2cccc(N(c3ccc4c(c3)sc3ccc(N(c5ccccc5)c5ccccc5)cc34)c3cc4c(cc3N(c3ccccc3)c3ccccc3)sc3ccccc34)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GPR3 P46089 1/20 0.38
▸ CYP1A2 P05177 2/20 0.35
▸ PTPN7 P35236 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ PTPN12 Q05209 1/20 0.33
▸ PTPN22 Q9Y2R2 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ PTGIR P43119 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21936956 1.00 MAPT (0.40) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL24088294 0.97 MAPT (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL21936517 0.97 MAPT (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL22506148 0.94 GPR3 (0.42) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL24883223 0.93 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19429044 0.93 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL23515775 0.93 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19429050 0.93 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19801846 0.93 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19429098 0.93 MAPT (0.45) MAPTALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380568-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-12-09 — — US disclosed
WO-2020085797-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2020-04-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380568-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, VDAC2 MAPT 775/4885ALDH1A1 1275/4885HPGD 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback